share_log

Goldman Sachs Maintains Buy on Calumet Specialty Prods, Lowers Price Target to $17

Goldman Sachs Maintains Buy on Calumet Specialty Prods, Lowers Price Target to $17

高盛维持对Calumet Specialty Prods的买入,将目标股价下调至17美元
Benzinga ·  03/21 11:37

Goldman Sachs analyst Neil Mehta maintains Calumet Specialty Prods (NASDAQ:CLMT) with a Buy and lowers the price target from $19 to $17.

高盛分析师尼尔·梅塔维持Calumet Specialty Prods(纳斯达克股票代码:CLMT)的买入并将目标股价从19美元下调至17美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发